These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11249567)

  • 1. Pharmacotherapy of atrial fibrillation.
    Nemec J; Shen WK
    Expert Opin Pharmacother; 1999 Nov; 1(1):81-96. PubMed ID: 11249567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.
    Crijns HJ
    Drugs; 2005; 65(12):1651-67. PubMed ID: 16060699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic drugs in atrial fibrillation: an overview of new agents, their mechanisms of action and potential clinical utility.
    Choudhury A; Lip GY
    Expert Opin Investig Drugs; 2004 Jul; 13(7):841-55. PubMed ID: 15212622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of atrial fibrillation: an old option with new possibilities.
    Janko S; Dorwarth U; Hoffmann E
    Expert Opin Pharmacother; 2008 Apr; 9(6):913-25. PubMed ID: 18377335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for conversion of atrial fibrillation.
    Dell'Orfano JT; Luck JC; Wolbrette DL; Patel H; Naccarelli GV
    Am Fam Physician; 1998 Aug; 58(2):471-80. PubMed ID: 9713400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological approaches in the treatment of atrial fibrillation.
    Tamargo J; Caballero R; Delpón E
    Curr Med Chem; 2004 Jan; 11(1):13-28. PubMed ID: 14754423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization.
    Singh BN; Mody FV; Lopez B; Sarma JS
    Am J Cardiol; 1999 Nov; 84(9A):161R-173R. PubMed ID: 10568677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological cardioversion of atrial fibrillation: current management and treatment options.
    Boriani G; Diemberger I; Biffi M; Martignani C; Branzi A
    Drugs; 2004; 64(24):2741-62. PubMed ID: 15563247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic management of atrial fibrillation: established and emerging options.
    Kalus JS
    J Manag Care Pharm; 2009 Aug; 15(6 Suppl B):S10-8. PubMed ID: 19678722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy for termination of atrial fibrillation and maintenance of sinus rhythm.
    Talajic M; Roy D
    Can J Cardiol; 2005 Sep; 21 Suppl B():19B-25B. PubMed ID: 16239983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paroxysmal atrial fibrillation: which anti-arrhythmic treatment?].
    Extramiana F; Messali A; Moubarak G; Leenhardt A
    Presse Med; 2010 Jun; 39(6):688-93. PubMed ID: 20400260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of contemporary antiarrhythmic drug therapy for maintenance of sinus rhythm in atrial fibrillation.
    Singla S; Karam P; Deshmukh AJ; Mehta J; Paydak H
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):12-20. PubMed ID: 21335483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate versus rhythm control in atrial fibrillation.
    Anthony KK; Mauro VF
    Ann Pharmacother; 2004 May; 38(5):839-44. PubMed ID: 15039475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Class I drugs on atrial fibrillation.
    Steinbeck G; Remp T; Hoffmann E
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S104-8. PubMed ID: 9727684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dronedarone: a promising alternative for the management of atrial fibrillation.
    Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Restoration and maintenance of sinus rhythm in patients with atrial fibrillation. New pharmacological approaches].
    Runge S; Dietz R; Haverkamp W
    Dtsch Med Wochenschr; 2008 Dec; 133(49):2572-8. PubMed ID: 19039713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New pharmacological approaches to atrial fibrillation.
    Milnes JT; Madge DJ; Ford JW
    Drug Discov Today; 2012 Jul; 17(13-14):654-9. PubMed ID: 22370250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological therapy of atrial fibrillation.
    Patton KK; Page RL
    Expert Opin Investig Drugs; 2007 Feb; 16(2):169-79. PubMed ID: 17243937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ; Markham A
    Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.